Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 19;21(6):2122. doi: 10.3390/ijms21062122

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Intracellular cytokine analysis by flow cytometry. Health donor-derived PBMC (N = 4) were treated with PB-derived mitochondria at 200 µg/mL (N = 4) in duplicate for 3 days in the presence of T-cell activator CD3/CD28 Dynabeads. (A–H) There were no marked differences in the percentages of IL-1β (A), IL-4 (B), IL-5 (C), IL-10 (D), IL-13 (E), TGF-β1 (G), and TNF-α (H)-producing cells after the treatment with PB-derived mitochondria. (F) Downregulation of the percentage of IL-17A-positive cells after the treatment with PB-derived mitochondria. Data were given as mean ± SD (standard deviation, N = 4).